Michael Matson
Stock Analyst at Needham
(2.82)
# 2,666
Out of 4,386 analysts
1623
Total ratings
44.4%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Buy | $120 → $101 | $80.69 | +25.17% | 96 | Jun 3, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $48 → $57 | $47.27 | +20.58% | 35 | Jun 1, 2026 | |
| ICUI ICU Medical | Upgraded: Buy | $165 | $137.48 | +20.02% | 13 | May 27, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $77 | $48.70 | +58.11% | 126 | May 18, 2026 | |
| ENOV Enovis | Maintained: Buy | $52 | $23.68 | +119.59% | 17 | May 18, 2026 | |
| RMD ResMed | Maintained: Hold | n/a | $193.14 | - | 94 | May 15, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $9 | $5.72 | +57.34% | 35 | May 14, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $0.9581 | +213.12% | 32 | May 14, 2026 | |
| STE STERIS | Maintained: Hold | n/a | $210.03 | - | 33 | May 12, 2026 | |
| AORT Artivion | Maintained: Buy | $58 → $44 | $20.39 | +115.79% | 57 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.06 | +98.02% | 86 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $10.04 | +19.52% | 37 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $74.88 | - | 46 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $147 | $131.74 | +11.58% | 69 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.96 | +66.91% | 101 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $74.80 | +8.29% | 86 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $74.84 | +14.91% | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $174 → $142 | $71.14 | +99.61% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.50 | - | 39 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $90 | $66.03 | +36.30% | 68 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $454 → $418 | $301.53 | +38.63% | 73 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $18.23 | +64.56% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 | $34.49 | +4.26% | 81 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $10.95 | +36.99% | 38 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $87.27 | - | 88 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $320.07 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $179.94 | - | 69 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.035 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $82 | $78.30 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $14.97 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.70 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.05 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $8.06 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $636 | $418.61 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $7.38 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.69 | n/a | 1 | Apr 17, 2009 |
Medtronic
Jun 3, 2026
Reiterated: Buy
Price Target: $120 → $101
Current: $80.69
Upside: +25.17%
Veracyte
Jun 1, 2026
Reiterated: Buy
Price Target: $48 → $57
Current: $47.27
Upside: +20.58%
ICU Medical
May 27, 2026
Upgraded: Buy
Price Target: $165
Current: $137.48
Upside: +20.02%
Boston Scientific
May 18, 2026
Reiterated: Buy
Price Target: $77
Current: $48.70
Upside: +58.11%
Enovis
May 18, 2026
Maintained: Buy
Price Target: $52
Current: $23.68
Upside: +119.59%
ResMed
May 15, 2026
Maintained: Hold
Price Target: n/a
Current: $193.14
Upside: -
Insight Molecular Diagnostics
May 14, 2026
Maintained: Buy
Price Target: $9
Current: $5.72
Upside: +57.34%
Lucid Diagnostics
May 14, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9581
Upside: +213.12%
STERIS
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $210.03
Upside: -
Artivion
May 8, 2026
Maintained: Buy
Price Target: $58 → $44
Current: $20.39
Upside: +115.79%
May 8, 2026
Maintained: Buy
Price Target: $12
Current: $6.06
Upside: +98.02%
May 8, 2026
Reiterated: Buy
Price Target: $12
Current: $10.04
Upside: +19.52%
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $74.88
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $147
Current: $131.74
Upside: +11.58%
May 6, 2026
Reiterated: Buy
Price Target: $45
Current: $26.96
Upside: +66.91%
May 6, 2026
Reiterated: Buy
Price Target: $81
Current: $74.80
Upside: +8.29%
May 6, 2026
Reiterated: Buy
Price Target: $86
Current: $74.84
Upside: +14.91%
May 6, 2026
Maintained: Buy
Price Target: $174 → $142
Current: $71.14
Upside: +99.61%
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $13.50
Upside: -
May 1, 2026
Maintained: Buy
Price Target: $101 → $90
Current: $66.03
Upside: +36.30%
May 1, 2026
Reiterated: Buy
Price Target: $454 → $418
Current: $301.53
Upside: +38.63%
May 1, 2026
Reiterated: Buy
Price Target: $30
Current: $18.23
Upside: +64.56%
Apr 30, 2026
Maintained: Hold
Price Target: $36
Current: $34.49
Upside: +4.26%
Apr 29, 2026
Maintained: Buy
Price Target: $15
Current: $10.95
Upside: +36.99%
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $87.27
Upside: -
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $320.07
Upside: -
Feb 17, 2026
Maintained: Hold
Price Target: n/a
Current: $179.94
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.035
Upside: n/a
May 5, 2021
Maintained: Buy
Price Target: $65 → $82
Current: $78.30
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: $27
Current: $14.97
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $3.70
Upside: n/a
Nov 11, 2016
Maintained: Buy
Price Target: n/a
Current: $2.05
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $8.06
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $636
Current: $418.61
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $7.38
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $9.69
Upside: n/a